MROH7-TTC4 (Gene)

Organism:

Homo sapiens

Gene:

MROH7-TTC4 associations

Synonyms:C1orf175, ENTREZ:100527960, HEATR8, HEATR8-TTC4, HGNC:49180, MROH7, MROH7-TTC4 readthrough (NMD candidate), MROH7-TTC4, NR_037639, NR_037640, NR_037641

Id:ENSG00000271723

Entrez:100527960

Ensembl:ENSG00000271723

Description:MROH7-TTC4 readthrough (NMD candidate)

This locus represents naturally occurring read-through transcription between the neighboring MROH7 (maestro heat-like repeat family member 7) and TTC4 (tetratricopeptide repeat domain 4) genes. Alternative splicing results in multiple transcript variants, which are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to produce protein products. [provided by RefSeq, Aug 2013]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View MROH7-TTC4's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with MROH7-TTC4.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using MROH7-TTC4.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for MROH7-TTC4.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with MROH7-TTC4.

Results found

Linked to

	Label	Description
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE80098 GSE80366 progesterone 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	RXFP4 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE139016 disulfiram 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115395 enzalutamide LNCaP 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE162892 ISOX 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE122979 GSE122980 LCL-161 MCF-7 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE80098 GSE80366 progesterone 0 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

RXFP4 IDG GPCR ARCHS4 coexpression

Gene Set (Entity type)

A Gene Set from IDG

GSE139016 disulfiram 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115395 enzalutamide LNCaP 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE162892 ISOX 4 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE122979 GSE122980 LCL-161 MCF-7 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.